Fecal Microbiota Transplants: The Future of Gut Health?
Ben Greenfield's April 2026 podcast explores fecal microbiota transplants with Novel Biome CEO Jason Klop, examining FMT's potential to reshape gut and brain he
A new episode of Ben Greenfield's podcast, published April 11, 2026 via Omny.fm, puts fecal microbiota transplants (FMTs) under the spotlight as a potentially transformative tool in gut health. Featuring Jason Klop, CEO of Novel Biome, the episode explores how transferring donor microbiome material into a recipient's gut could reshape the treatment of microbiome-related conditions — a topic drawing growing attention from researchers studying the gut-brain axis.
Why This Matters
The human gut microbiome — comprising trillions of bacteria, fungi, and other microorganisms — is now understood to influence not only digestive health but also immune function, mental health, and neurological wellbeing. Per the episode's framing, FMTs represent one of the most direct ways to intervene in a disrupted microbiome. As scientific interest in the gut-brain connection accelerates globally, therapies that can measurably restore microbial balance are attracting both clinical and public interest at an unprecedented pace.
Novel Biome's Approach to FMT Science
According to the podcast, Jason Klop and Novel Biome are positioned at the cutting edge of FMT development, working to translate what has historically been a niche clinical procedure into a more accessible and standardised format — colloquially referenced as "poop pills." The concept of encapsulated fecal microbiota represents a significant shift in how gut-restoring therapies could be delivered to patients. Per the episode, Klop brings specialised insight into donor screening, formulation, and the regulatory landscape surrounding FMT products.
What This Means for People With Gut and Brain Health Concerns
For individuals managing conditions linked to microbiome imbalance — ranging from irritable bowel syndrome to anxiety and cognitive issues tied to the gut-brain axis — FMT research signals a potential new frontier. Per the Omny.fm episode, the science is advancing toward more practical delivery mechanisms, which could eventually broaden patient access. Clinicians and health-focused consumers alike are watching this space closely as evidence builds.
The central takeaway from Ben Greenfield's conversation with Jason Klop, per the April 2026 episode, is that fecal microbiota transplants are no longer fringe science. As microbiome research matures and the gut-brain relationship becomes better understood, FMT may emerge as one of the most evidence-backed biohacks available — though regulatory and clinical pathways remain a key factor in determining how quickly these therapies reach mainstream use.